David Lammy lifts cap on court sitting days in effort to cut backlog of cases
Criminal barristers welcome justice secretary’s move to remove limit on hearing days at crown courts in England and WalesA cap on court sitting days...
Last updated: 2026-02-24 07:44:35 ET
Pulse AI Brief
Updated Feb 24, 2026 6:00 AM ET
FedEx has filed a lawsuit against the Trump administration, seeking a full refund of the tariffs it paid under policies recently invalidated by the Supreme Court. The logistics giant argues that the tariffs were unlawfully imposed and seeks reimbursement with interest.
The lawsuit could set a precedent for other companies seeking similar refunds, potentially impacting government revenue and corporate financial statements. FedEx shares may see volatility as the legal proceedings unfold.
This legal action highlights the contentious nature of tariff policies and their implications for international trade and corporate strategy.
Criminal barristers welcome justice secretary’s move to remove limit on hearing days at crown courts in England and WalesA cap on court sitting days...
'Scratches the surface'
Dueling pro-AI PACs have centered around backing or targeting one New York congressional bid: Alex Bores, whose RAISE Act requires AI developers to disclose safety protocols and report serious system misuse.
A coalition of more than a dozen Republican attorneys general is demanding that a taxpayer-funded scientific organization scrub a politically biased c...
Programme that funds groups building tech to evade oppressive government controls under serious threatFor nearly two decades, the US quietly funded a ...
The UK and Welsh governments have agreed a long-term rail investment plan that includes seven new stations and a pipeline of projects estimated at up ...
CEO said services have restarted after termination of grants led to criticism that US was ceding ground to ChinaRadio Free Asia has resumed broadcasts...
MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the "Company"), (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical c...